SMT201400170B - Vaccino contro hpv - Google Patents

Vaccino contro hpv

Info

Publication number
SMT201400170B
SMT201400170B SM201400170T SM201400170T SMT201400170B SM T201400170 B SMT201400170 B SM T201400170B SM 201400170 T SM201400170 T SM 201400170T SM 201400170 T SM201400170 T SM 201400170T SM T201400170 B SMT201400170 B SM T201400170B
Authority
SM
San Marino
Prior art keywords
vaccine against
against hpv
hpv
vaccine
Prior art date
Application number
SM201400170T
Other languages
English (en)
Italian (it)
Inventor
Dominique Descamps
Sandra Giannini
Nicolas Lecrenier
Jean Stephenne
Martine Anna Cecile Wettendorff
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of SMT201400170B publication Critical patent/SMT201400170B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SM201400170T 2008-07-31 2014-11-10 Vaccino contro hpv SMT201400170B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8510108P 2008-07-31 2008-07-31
US17656109P 2009-05-08 2009-05-08
PCT/EP2009/059820 WO2010012780A1 (en) 2008-07-31 2009-07-29 Vaccine against hpv

Publications (1)

Publication Number Publication Date
SMT201400170B true SMT201400170B (it) 2015-01-15

Family

ID=41139260

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400170T SMT201400170B (it) 2008-07-31 2014-11-10 Vaccino contro hpv

Country Status (26)

Country Link
US (1) US20110189229A1 (enExample)
EP (1) EP2318042B1 (enExample)
JP (1) JP6022159B2 (enExample)
KR (1) KR20110053340A (enExample)
CN (1) CN102159239A (enExample)
AU (1) AU2009275909A1 (enExample)
BR (1) BRPI0916732B1 (enExample)
CA (1) CA2732436C (enExample)
CO (1) CO6341567A2 (enExample)
DK (1) DK2318042T3 (enExample)
DO (1) DOP2011000031A (enExample)
EA (1) EA201170264A1 (enExample)
ES (1) ES2519490T3 (enExample)
HR (1) HRP20141063T1 (enExample)
IL (1) IL210977A0 (enExample)
MA (1) MA32554B1 (enExample)
MX (1) MX2011001218A (enExample)
NZ (1) NZ590919A (enExample)
PE (1) PE20110327A1 (enExample)
PL (1) PL2318042T3 (enExample)
PT (1) PT2318042E (enExample)
RS (1) RS53607B1 (enExample)
SI (1) SI2318042T1 (enExample)
SM (1) SMT201400170B (enExample)
WO (1) WO2010012780A1 (enExample)
ZA (1) ZA201100889B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2768172A1 (en) 2009-06-25 2010-12-29 Glaxosmithkline Biologicals S.A. Novel compositions
CN102178944A (zh) * 2010-09-17 2011-09-14 大连雅立峰生物制药有限公司 人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh) * 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
EP3191505A2 (en) * 2014-09-11 2017-07-19 Cadila Healthcare Limited Superior human papilloma virus antigens with superior immunological properties and vaccine containing it
US10063211B2 (en) 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
RU2628693C1 (ru) * 2016-11-10 2017-08-21 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ
US20210302427A1 (en) * 2020-03-31 2021-09-30 Shuhari Group, LLC Secure Immunity Information Transmission System And Network
KR20260109890A (ko) * 2024-01-04 2026-07-13 사이안백 엘엘씨 백신 조성물에 증가된 안정성을 제공하는 개선된 제형

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP1732598A4 (en) * 2003-12-31 2009-08-26 Pharmexa Inc TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
US7758866B2 (en) * 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
KR20070029254A (ko) * 2004-06-16 2007-03-13 글락소스미스클라인 바이오로지칼즈 에스.에이. Hpv 16과 hpv 18 및 적어도 hpv 31, 45 또는52로부터 선택된 또 다른 hpv 유형에 대한 백신
AR054259A1 (es) * 2005-04-26 2007-06-13 Glaxosmithkline Biolog Sa Vacuna contra virus de papiloma humano (hpv)

Also Published As

Publication number Publication date
DK2318042T3 (da) 2014-11-10
BRPI0916732B1 (pt) 2021-06-29
CO6341567A2 (es) 2011-11-21
CA2732436C (en) 2018-01-16
DOP2011000031A (es) 2011-02-28
NZ590919A (en) 2012-10-26
WO2010012780A1 (en) 2010-02-04
EP2318042B1 (en) 2014-08-20
MA32554B1 (fr) 2011-08-01
KR20110053340A (ko) 2011-05-20
US20110189229A1 (en) 2011-08-04
CN102159239A (zh) 2011-08-17
PL2318042T3 (pl) 2015-02-27
MX2011001218A (es) 2011-03-15
AU2009275909A1 (en) 2010-02-04
JP6022159B2 (ja) 2016-11-09
BRPI0916732A2 (pt) 2017-01-31
RS53607B1 (sr) 2015-04-30
SI2318042T1 (sl) 2014-12-31
CA2732436A1 (en) 2010-02-04
EP2318042A1 (en) 2011-05-11
PT2318042E (pt) 2014-11-05
JP2011529475A (ja) 2011-12-08
PE20110327A1 (es) 2011-06-29
IL210977A0 (en) 2011-04-28
HRP20141063T1 (hr) 2015-01-02
ES2519490T3 (es) 2014-11-07
ZA201100889B (en) 2012-04-25
EA201170264A1 (ru) 2011-08-30

Similar Documents

Publication Publication Date Title
BR112012006964A2 (pt) ventilador
DK2049559T3 (da) Forbedrede HPV vacciner
BRPI1006029A2 (pt) um ventilador
BRPI0922878A2 (pt) ventilador
DK2114993T3 (da) Vaccine
DK2581680T3 (da) Ventilatorenhed
EP2501439A4 (en) FAN
DK3477119T3 (da) Lydtæt heliko-centrifugalblæser
DK2370462T3 (da) Glucagon-analoger
BRPI0917205A2 (pt) vacina polivalente
BRPI0916732A2 (pt) vacina contra hpv
DK2422104T3 (da) Centrifugalkobling
PT2460655E (pt) Folha antisujidade
EP2326671A4 (en) LPS BASED VACCINES
BRPI0921578A2 (pt) vacinas unitemporais
DE102008016957A8 (de) Akkumulator-Ladevorrichtung
FI20090216L (fi) Paalu
DK2175881T3 (da) Intradermal influenzavaccine
CN301220337S (zh) 风扇
CN301220339S (zh) 风扇
CN301220338S (zh) 风扇
FI8374U1 (fi) Terärakenne
ES1067420Y (es) Ataud desmontable
FI8004U1 (fi) Lakana
UA17852S (uk) Вентилятор